Capecitabine, DNA/RNA Synthesis Inhibitor

Capecitabine is an oral proagent that is converted to its active metabolite, 5-FU, by thymidine phosphorylase. - Mechanism of Action & Protocol.

Capecitabine, C15H22FN3O6

Thymidine Monophosphate - an overview

Capecitabine, Drug Information, Uses, Side Effects, Chemistry

Targeting nucleotide metabolism: a promising approach to enhance cancer immunotherapy, Journal of Hematology & Oncology

Adjuvant capecitabine-containing chemotherapy benefit and homologous recombination deficiency in early-stage triple-negative breast cancer patients

Frontiers Co-delivery of Cisplatin(IV) and Capecitabine as an Effective and Non-toxic Cancer Treatment

View of Genetic factors affecting patient responses to pancreatic cancer treatment

5-FU (5-Fluorouracil), 99.97%(HPLC), In Stock

Tysinor 150 Mg Capecitabine USP

Drug combination and repurposing for cancer therapy: the example of breast cancer